SCHEMBL16893017

SCHEMBL16893017

Cc1cccc(-c2cnc(N)nc2-c2c[nH]c(OC(=O)NCCc3cccnc3)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 2/20 0.46
▸ PTAFR P25105 2/20 0.43
▸ MAPK1 P28482 1/20 0.41
▸ GSK3B P49841 1/20 0.39
▸ LIMK1 P53667 1/20 0.38
▸ LIMK2 P53671 1/20 0.38
▸ NAMPT P43490 4/20 0.38
▸ PTGFR P43088 1/20 0.38
▸ HCRTR1 O43613 1/20 0.37
▸ HCRTR2 O43614 1/20 0.37
▸ EPHX1 P07099 1/20 0.37
▸ CCNT1 O60563 1/20 0.37
▸ CCNA2 P20248 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ CDK9 P50750 1/20 0.37
▸ AAK1 Q2M2I8 1/20 0.37
▸ ADORA2A P29274 1/20 0.37
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16893078 0.91 GSK3B (0.47) ADORA1PTAFRMAPK1GSK3BLIMK1
SCHEMBL16893143 0.91 MAPK1 (0.52) ADORA1PTAFRMAPK1GSK3BLIMK1
SCHEMBL16893141 0.88 NAMPT (0.40) PTAFRMAPK1GSK3BLIMK1LIMK2
SCHEMBL16893034 0.88 ADORA1 (0.48) ADORA1PTAFRMAPK1ADORA2A
SCHEMBL16893116 0.84 NAMPT (0.38) MAPK1GSK3BLIMK1LIMK2NAMPT
SCHEMBL16893092 0.77 GSK3B (0.41) PTAFRMAPK1GSK3BNAMPTPTGFR
SCHEMBL16893103 0.76 ADORA1 (0.54) ADORA1MAPK1ADORA2A
SCHEMBL16892977 0.73 AKT3 (0.46) GSK3BCDK2HDAC2HDAC8HDAC6
SCHEMBL5397397 0.71 ADORA1 (0.66) ADORA1ADORA2A
SCHEMBL16893082 0.71 OPRM1 (0.42) ADORA1MAPK1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363906-B1 HETEROCYCLIC INHIBITORS OF ERK2 AND USES THEREOF VERTEX PHARMA (US) 2015-07-15 — — EP claimed
Send feedback